Products for Research Use Only

Benzarone

CAT: 0804-HY-W011711-01Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W011711-01Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Benzarone is an oral inhibitor of human urate transporter 1 (hURAT1) with an IC50 value of 2.8 μM, and it also acts as an uncoupler of oxidative phosphorylation. Benzarone can cause liver damage and promote cell apoptosis and necrosis. Benzarone can be used to lower serum uric acid levels and for research in vascular diseases[1][2][3].
CAS Number
1477-19-6
UNSPSC
12352005
Hazard Statement
H302, H413
Target
Apoptosis; Oxidative Phosphorylation; URAT1
Type
Reference compound
Related Pathways
Apoptosis; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/benzarone.html
Purity
99.68
Solubility
DMSO : ≥ 100 mg/mL
Smiles
CCC1=C(C(C2=CC=C(O)C=C2)=O)C3=CC=CC=C3O1
Molecular Formula
C17H14O3
Molecular Weight
266.29
Precautions
H302, H413
References & Citations
[1]Wempe MF, et, al. Developing potent human uric acid transporter 1 (hURAT1) inhibitors. J Med Chem. 2011 Apr 28;54 (8) :2701-13. |[2]Priska Kaufmann, et al. Mechanisms of benzarone and benzbromarone-induced hepatic toxicity. Hepatology. 2005 Apr;41 (4) :925-35.|[3]S G Wood, et al. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products